CN101375872A - 治疗糖尿病新药配方 - Google Patents
治疗糖尿病新药配方 Download PDFInfo
- Publication number
- CN101375872A CN101375872A CNA2007100165894A CN200710016589A CN101375872A CN 101375872 A CN101375872 A CN 101375872A CN A2007100165894 A CNA2007100165894 A CN A2007100165894A CN 200710016589 A CN200710016589 A CN 200710016589A CN 101375872 A CN101375872 A CN 101375872A
- Authority
- CN
- China
- Prior art keywords
- parts
- new
- new drug
- treating diabetes
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 12
- 229920001661 Chitosan Polymers 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 5
- 244000293323 Cosmos caudatus Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 229920002414 procyanidin Polymers 0.000 claims description 5
- HCEQQASHRRPQFE-UHFFFAOYSA-N 5-chloro-n-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide;3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N.COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 HCEQQASHRRPQFE-UHFFFAOYSA-N 0.000 claims description 3
- 229940112611 glucovance Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 239000002547 new drug Substances 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 239000009759 San-Chi Substances 0.000 abstract 1
- 229920002770 condensed tannin Polymers 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960000346 gliclazide Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗糖尿病新药配方，涉及一种中成药配制方法。其特征是新药配方配比是将壳寡糖1－30份、原花青素1－30份、珍珠粉1－20份、三七粉1－20份混合，分装入胶囊，获得所需成药。采用本发明制成的新药无毒副作用、疗效快、效果显著，制作工艺简便易行、在治疗糖尿病方面提供了新方法、新思路。
Description
技术领域
本发明涉及一种中成药配制方法。
背景技术
目前，在治疗糖尿病方面，常用的药物西药主要有二甲双胍，格列齐特，比格列酮等，此类药物大多有比较强的毒副作用，主要是控制血糖，提高胰岛素敏感度，对于胰腺的修复几乎没有作用。中药如参芪降糖，苦瓜提取物，南瓜提取物以及其他中药配方等，制备工艺繁杂，疗效慢，效果不是特别明显，也主要在表现在降糖作用上，忽略了胰腺的自我修复。
发明内容
为了克服现有技术的不足，本发明提供一种治疗糖尿病新药配方，以解决现有技术毒副作用大、疗效慢、效果差。
本发明解技术方案所指的新药制备方法配方配比是将壳寡糖1—30份、原花青素1—30份、珍珠粉1—20份、三七粉1—20份混合，分装入胶囊，获得所需成药。
采用本发明的积极效果是该新药无毒副作用、疗效快、效果显著，、制作工艺简便易行、在治疗糖尿病方面提供了新方法、新思路。
具体实施方式
根据糖尿病病情，采用不同的配比，制成所需新药，公开以下具体实施例：
实施例1
壳寡糖20公斤、原花青素10公斤、珍珠粉1公斤、三七粉1公斤混合均匀，分装入胶囊即成。
实施例2
壳寡糖20公斤、原花青素5公斤、珍珠粉4公斤、三七粉3公斤混合均匀，分装入胶囊即成。
实施例3
壳寡糖5公斤、原花青素20公斤、珍珠粉3公斤、三七粉4公斤混合均匀，分装入胶囊即成。
Claims (1)
1、一种治疗糖尿病新药配方，其特征是新药配方配比是将壳寡糖1-30份、原花青素1—30份、珍珠粉1—20份、三七粉1—20份混合，分装入胶囊，获得所需成药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100165894A CN101375872B (zh) | 2007-08-28 | 2007-08-28 | 治疗糖尿病新药配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100165894A CN101375872B (zh) | 2007-08-28 | 2007-08-28 | 治疗糖尿病新药配方 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101375872A true CN101375872A (zh) | 2009-03-04 |
| CN101375872B CN101375872B (zh) | 2011-03-30 |
Family
ID=40419718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100165894A Expired - Fee Related CN101375872B (zh) | 2007-08-28 | 2007-08-28 | 治疗糖尿病新药配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101375872B (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105105137A (zh) * | 2015-10-09 | 2015-12-02 | 福建师范大学 | 一种蓝莓花青素与壳寡糖组合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1044686C (zh) * | 1993-09-30 | 1999-08-18 | 于春江 | 一种治疗胃病的药物 |
| CN1358509A (zh) * | 2000-12-12 | 2002-07-17 | 陈宝贵 | 珍珠多效面露 |
| CN1212133C (zh) * | 2002-05-16 | 2005-07-27 | 潘晓书 | 美容保健组合物及其制备方法 |
| CN1480209A (zh) * | 2003-07-18 | 2004-03-10 | 陈 列 | 复方峰胶制剂的加工方法 |
-
2007
- 2007-08-28 CN CN2007100165894A patent/CN101375872B/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105105137A (zh) * | 2015-10-09 | 2015-12-02 | 福建师范大学 | 一种蓝莓花青素与壳寡糖组合物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101375872B (zh) | 2011-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Preparation and antidiabetic activity of polysaccharide from Portulaca oleracea L. | |
| AbuKhader | Thymoquinone: a promising antidiabetic agent | |
| CN105287511A (zh) | 土甘草a的应用 | |
| CN102178821B (zh) | 一种降血糖的软胶囊及其制备方法 | |
| GB2503628A (en) | Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight | |
| CN104906199A (zh) | 一种荞麦壳黄酮类提取物及作为dpp4抑制剂的用途 | |
| CN106943372A (zh) | 一种辅助降血糖软胶囊及其生产工艺 | |
| CN101375872B (zh) | 治疗糖尿病新药配方 | |
| CN112587575A (zh) | 一种治疗糖尿病的具有抗氧化功能的药物组合物 | |
| CN102311474A (zh) | 应用无溶剂法制备原人参二醇和原人参三醇 | |
| CN105343140A (zh) | 一种麻黄根总有效部位及其制备方法和抗癌应用 | |
| Issac et al. | Tannins of Jatropha Gossypifolia Exert Anti-Hyperlipidemic Effect in Streptozotocin-Nicotinamide induced Diabetic Rats | |
| CN109043545A (zh) | 一种复合生物素营养制剂及其制备方法、应用 | |
| CN104491339A (zh) | 一种防治高脂血症及抗血栓的沙棘叶组合物及制备方法 | |
| CN1199643C (zh) | 知母总皂苷用于制备防治脑卒中药物的用途 | |
| CN101590087A (zh) | 一种延缓女性衰老的组合物及其制备方法 | |
| CN102166259B (zh) | 一种双黄酮胶囊、片剂配制方法 | |
| CN1611232A (zh) | 一种以抗疲劳、抗辐射、抗忧郁为主功效的药物组合物及其制法 | |
| CN106387352A (zh) | 一种含茶多酚的微胶囊动物免疫增强剂及其制备方法 | |
| CN104523795A (zh) | 鹿茸糖肽组合物在制备耐缺氧药品及保健食品中的应用 | |
| CN108434187A (zh) | 治疗糖尿病新药配方 | |
| CN106420932B (zh) | 一种增加胰岛素敏感性的组合物及其应用 | |
| CN100441181C (zh) | 一种治疗高脂血症的丹蓝微丸胶囊药物的制备方法和应用 | |
| KR20200132439A (ko) | 발효 인삼을 함유하는 정제의 제조방법 | |
| CN114053282B (zh) | 委陵菜酸和山莨菪碱胶囊在制备治疗糖尿病药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WEIHAI JINGDA BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: FENG DAQING Effective date: 20110824 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 253035 DEZHOU, SHANDONG PROVINCE TO: 264209 WEIHAI, SHANDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110824 Address after: 264209 Cultural West Road, Weihai, Shandong 2305, 177A Patentee after: Weihai king of Biological Technology Co., Ltd. Address before: 253035 dormitory 2-501, Evergreen Street, Decheng District, Shandong City, Dezhou Province Patentee before: Feng Daqing |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110330 Termination date: 20150828 |
|
| EXPY | Termination of patent right or utility model |